The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1
Abstract
Background An elevated basal serum tryptase level is associated with severe systemic anaphylaxis, most notably caused by Hymenoptera envenomation. Although clonal mast cell disease is the culprit in some individuals, it does not fully explain this clinical association.Objective Our aim was to determine the prevalence and associated impact of tryptase genotypes on anaphylaxis in humans.Methods Cohorts with systemic mastocytosis (SM) and venom as well as idiopathic anaphylaxis from referral centers in Italy, Slovenia, and the United States, underwent tryptase genotyping by droplet digital PCR. Associated anaphylaxis severity (Mueller scale) was subsequently examined. Healthy volunteers and controls with nonatopic disease were recruited and tryptase was genotyped by droplet digital PCR and in silico analysis of genome sequence, respectively. The effects of pooled and recombinant human tryptases, protease activated receptor 2 agonist and antagonist peptides, and a tryptase-neutralizing mAb on human umbilical vein endothelial cell permeability were assayed using a Transwell system.Results Hereditary α-tryptasemia (HαT)-a genetic trait caused by increased α-tryptase-encoding Tryptase-α/β1 (TPSAB1) copy number resulting in elevated BST level-was common in healthy individuals (5.6% [n = 7 of 125]) and controls with nonatopic disease (5.3% [n = 21 of 398]). HαT was associated with grade IV venom anaphylaxis (relative risk = 2.0; P < .05) and more prevalent in both idiopathic anaphylaxis (n = 8 of 47; [17%; P = .006]) and SM (n = 10 of 82 [12.2%; P = .03]) relative to the controls. Among patients with SM, concomitant HαT was associated with increased risk for systemic anaphylaxis (relative risk = 9.5; P = .007). In vitro, protease-activated receptor-2-dependent vascular permeability was induced by pooled mature tryptases but not α- or β-tryptase homotetramers.Conclusions Risk for severe anaphylaxis in humans is associated with inherited differences in α-tryptase-encoding copies at TPSAB1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further, H a T may be associated with an increased severity of anaphylactic reactions and other mediator-induced symptoms in patients with mastocytosis and venom allergy. 25,129”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [129]
In the citing paper
“in patients with SM, where it can reach up to 12%–20% (17, 19, 22, 23).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [17]
In the citing paper
“severe episodes were twice more frequent in individuals with both SM and HαT than in those with SM but without HαT (17, 18).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [17]
In the citing paper
“There is a consensus that HαT is a risk modifier of severe anaphylaxis [21,48,49,50,51,52,53].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [48]
In the citing paper
“A recent description of a / b -tryptase heterotetrameric tryptases, which have expanded biologic functions relative to mature b -tryptases, may offer a possible mechanism explaining MCA in these individuals. 128,129”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [129]
In the citing paper
“However, an approximately two to three times higher prevalence of H a T has been reported in two large cohorts of SM patients 25,129 ; also, H a T concurrently occurring with MCAS has been reported. 130,131”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [129]
In the citing paper
“HαT is enriched in patients with SM,42,43 in Hymenoptera-allergic patients with severe anaphylaxis,44,45 and in patients with idiopathic anaphylaxis.42,43,45,46”
From Mast cell activation syndrome: Current understanding and research needs (2024) · cites this paper as [45]
In the citing paper
“because HaT has been shown to be an independent heritable genetic risk factor of severe anaphylaxis.23”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [23]
Citations
Cites
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Riewald, M., Petrovan, R. J., Donner, A. J., Mueller, B. M., & Ruf, W. (2002) · Science · doi:10.1126/science.1071699 · Cited by 832
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Valent, P., Akin, C., & Metcalfe, D. D. (2016) · Blood · doi:10.1182/blood-2016-09-731893 · Cited by 698
Self-citationBrockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Diagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477
Self-citationRuëff, F., Bernhard Przybilla, A., Bilò, M. B., Müller, U., Scheipl, F., Aberer, W., Birnbaum, J., Bodzenta‐Łukaszyk, A., Bonifazi, F., Bucher, C., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.027 · Cited by 429
Diagnosis and Treatment of Insect Sensitivity
Mueller, H. L. (1966) · Journal of Asthma Research · doi:10.3109/02770906609106941 · Cited by 425
Lyons, J. J., Yu, X., Hughes, J. D., Le, Q. T., Jamil, A., Bai, Y., Ho, N., Zhao, M., Liu, Y., O'Connell, M. P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3696 · Cited by 394
Self-citationMast Cell Tryptase Controls Paracellular Permeability of the Intestine
Jacob, C., Yang, P.-C., Darmoul, D., Amadesi, S., Saito, T., Cottrell, G. S., Coelho, A.-M., Singh, P., Grady, E. F., Perdue, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506338200 · Cited by 334
Epidemiology of systemic mastocytosis in Denmark
Cohen, S. S., Skovbo, S., Vestergaard, H., Kristensen, T. K., Møller, M. B., Bindslev‐Jensen, C., Fryzek, J. P., & Broesby‐Olsen, S. (2014) · British Journal of Haematology · doi:10.1111/bjh.12916 · Cited by 235
Haeberli, G., Brönnimann, M. P., Hunziker, T., & Müller, U. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01755.x · Cited by 222
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 231
Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update
Wang, J., Lieberman, J. A., Wallace, D. V., Waserman, S., & Golden, D. B. K. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.06.036 · Cited by 13
Mast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management
Boggs, N. A., Tanasi, I., Hartmann, K., Zanotti, R., & González‐de‐Olano, D. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.08.034 · Cited by 16
Self-citationHypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
Carosi, G., Guabello, G., Longhi, M., Grifoni, F. I., Passeri, E., & Corbetta, S. (2020) · Mediators of Inflammation · doi:10.1155/2020/5785378 · Cited by 13
Vazquez, M., Chovanec, J. F., Kim, J., DiMaggio, T., Milner, J. D., Francomano, C. A., Gurnett, C. A., Ritelli, M., Colombi, M., & Lyons, J. J. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100094 · Cited by 13
Self-citationManagement of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis
Gülen, T. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.010 · Cited by 14
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
Tanasi, I., Crosera, L., Taus, F., Orsolini, G., Adami, G., Olivieri, F., Bernardelli, A., Bonadonna, P., Nalin, F., Sella, S., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117141 · Cited by 12
Self-citationDribin, T. E., & Castells, M. (2021) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.10.002 · Cited by 12
Mast Cell Activation Syndrome Update—A Dermatological Perspective
Mihele, D., Nistor, P., Bruma, G., Mitran, C. I., Mitran, M. I., Condrat, C. E., Țovaru, M., Tampa, M. Ş., & Georgescu, S. R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071116 · Cited by 14
McMurray, J. C., Pacheco, C. S., Schornack, B. J., Sun, X., Brunader, J. A., Scott, A. E., Ariza, J. S., Kou, C.-T. J., Costantino, R. C., Pittman, L. M., et al. (2024) · Blood · doi:10.1182/blood.2023023347 · Cited by 11
Self-citationChallenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis
Giannetti, M. P., Nicoloro‐SantaBarbara, J. M., Godwin, G., Middlesworth, J., Espeland, A., Douvas, J. L., & Castells, M. (2024) · Diagnostics · doi:10.3390/diagnostics14020123 · Cited by 11
Clinically accessible amplitude-based multiplex ddPCR assay for tryptase genotyping
Svetina, M., Šelb, J., Lyons, J. J., Korošec, P., & Rijavec, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-52983-8 · Cited by 13
Self-citationAnaphylaxis: Advances in the Past 10 Years
Weiler, C. R., Schrijvers, R., & Golden, D. B. K. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.09.019 · Cited by 13
Anaphylaxis to Stinging Insect Venom
Adams, K. E., Tracy, J. M., & Golden, D. B. K. (2021) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.09.003 · Cited by 11
Valent, P., Arock, M., Akin, C., & Metcalfe, D. D. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.041 · Cited by 11
Self-citationDefining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: Are we there yet?
Couto, M. L., Silva, M., Barbosa, M. J., Ferreira, F., Fragoso, A. S., & Azenha Rama, T. (2023) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.288 · Cited by 10
Chatain, C., Sedillot, N., Thomas, M., Pernollet, M., Bocquet, A., Boccon‐Gibod, I., Bouillet, L., & Leccia, M. ‐. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.08.005 · Cited by 9
Anaphylaxis: Focus on Transcription Factor Activity
Guo, Y., Proaño-Pérez, E., Muñoz‐Cano, R., & Martı́n, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094935 · Cited by 9
Detection of clonal mast cell disease in wasp venom allergic patients with normal tryptase
Onnes, M. C., Alheraky, A., Nawijn, M. C., Sluijter, T. E., Mulder, A. B., Arends, S., & Oude Elberink, H. N. G. (2022) · Clinical and Translational Allergy · doi:10.1002/clt2.12174 · Cited by 8
Cold-induced anaphylaxis: new insights into clinical and genetic characteristics
Bizjak, M., Korošec, P., Košnik, M., Šelb, J., Bidovec‐Stojkovič, U., Svetina, M., Zver, S., Dinevski, D., & Rijavec, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1558284 · Cited by 10
Self-citationWhat the clinician should know when ordering a mast cell tryptase test
Michel, M., Giusti, D., Klingebiel, C., Pham, B., & Vitte, J. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.03.003 · Cited by 9
Expanding the Immunologic and Neuronal Landscape of IgE‐Mediated Anaphylaxis
Biswas, R., Fried, J. M., & de Lafaille, M. A. C. (2025) · Immunological Reviews · doi:10.1111/imr.70078 · Cited by 8
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers
Lyons, J. J., Farkas, H., Germenis, A. E., Rijavec, M., Smith, T., & Valent, P. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.031 · Cited by 11
Self-citationPrevention of Anaphylaxis Episodes in Idiopathic Anaphylaxis by Omalizumab
Košnik, M., Zugan, L., & Rijavec, M. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000538046 · Cited by 7
Self-citationZama, D., Muratore, E., Giannetti, A., Neri, I., Conti, F., Magini, P., Ferrari, S., & Pession, A. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.716786 · Cited by 7
Recent update on the management of anaphylaxis
Quoc, Q. L., Cao, T. B. T., Jang, J.-H., & Park, H. (2021) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.21.121 · Cited by 7
Pitlick, M. M., Park, M. A., Gonzalez‐Estrada, A., & Chiarella, S. E. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.07.020 · Cited by 7
Glover, S. C., Carlyle, A., & Lyons, J. J. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.12.008 · Cited by 7
Self-citationSvetina, M., Kunej, T., Korošec, P., & Rijavec, M. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09069-8 · Cited by 7
Self-citationRijavec, M., Maver, A., Turner, P., Hočevar, K., Košnik, M., Yamani, A. N., Hogan, S. P., Čustović, A., Peterlin, B., & Korošec, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016165 · Cited by 6
Self-citationInsights into the clinical, immunologic, and genetic underpinnings of food allergy
Frischmeyer‐Guerrerio, P. A., Young, F. D., Aktaş, O. N., & Haque, T. T. (2024) · Immunological Reviews · doi:10.1111/imr.13371 · Cited by 7
Anaphylaxis viewed by experts: unmet needs
Sala-Cunill, A., & Cardona, V. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000771 · Cited by 6
L'anaphylaxie et les vaccins COVID-19
Castells, M., Demoly, P. M., & Tanno, L. K. (2021) · Revue française d'allergologie · doi:10.1016/s1877-0320(21)00439-5 · Cited by 6
Khalid, M. B., Zektser, E., Chu, E., Li, M., Utoh, J., Ryan, P. B., Loving, H. S., Harb, R., Kattappuram, R., Chatman, L., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.03.001 · Cited by 6
Self-citationVitte, J., Gonzalez, C., Klingebiel, C., & Michel, M. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.02.218 · Cited by 5
Case Report: A family history of peanut allergy and hereditary alpha-tryptasemia
Chantran, Y., Renaudin, H., Arock, M., Guiddir, T., & Nemni, A. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2023.1322117 · Cited by 6
Lim, J., Ross, D. M., Brown, A. L., Scott, H. S., & Hahn, C. N. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107566 · Cited by 5
Luzar, A. D., Otorepec, J., Košnik, M., Kopač, P., Šelb, J., Korošec, P., & Rijavec, M. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.70019 · Cited by 5
Self-citationPouessel, G., Egea, C., Divaret‐Chauveau, A., Beaumont, P., Bradatan, E., Dumond, P., Diesnis, R., Tscheiller, S., van der Brempt, X., Braun, C., et al. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.70089 · Cited by 5
Loli‐Ausejo, D., González-Matamala, M. F., Martí, D., Ruano-Zaragoza, M., Mir‐Ihara, P., Solis‐Ynga, K., Lara, R., Bartra, J., Pascal, M., & Muñoz‐Cano, R. (2025) · Allergy · doi:10.1111/all.16623 · Cited by 5
Update in stinging insect hypersensitivity
Golden, D. B. K. (2025) · Allergy and Asthma Proceedings · doi:10.2500/aap.2025.46.250060 · Cited by 5
Alpha-Tryptase Overexpression as a Modifier of Mast Cell–Mediated Reactions
Korošec, P., González‐de‐Olano, D., & Lyons, J. J. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.018 · Cited by 6
Self-citationCutaneous Manifestations in Hereditary Alpha Tryptasemia
Kranyak, A. C. (2023) · Cutis · doi:10.12788/cutis.0682 · Cited by 5
Ballul, T., Sabato, V., Valent, P., Hermine, O., Lortholary, O., Rossignol, J., Ballul, T., Sabato, V., Livideanu, C. B., Neuraz, A., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103043 · Cited by 6
Decoding the intricacies of the mast cell compartment
Carter, M. C., & Metcalfe, D. D. (2021) · British Journal of Haematology · doi:10.1111/bjh.17714 · Cited by 5
Self-citationMast Cell Disorders of the Gastrointestinal Tract
Panarelli, N. C. (2023) · Surgical pathology clinics · doi:10.1016/j.path.2023.05.010 · Cited by 5
Lyons, J. J. (2024) · Allergy and Asthma Proceedings · doi:10.2500/aap.2025.46.240088 · Cited by 5
Self-citationManagement of indolent mastocytosis and mast cell activation syndrome
Akin, C., Butterfield, J. H., Castells, M., & Lyons, J. J. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.06.032 · Cited by 5
Self-citationHoermann, G., Orfao, A., Lyons, J. J., Chantran, Y., Broesby‐Olsen, S., Sabato, V., & Arock, M. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.07.055 · Cited by 4
Self-citationBen‐Shoshan, M., Cem, A., Cook, V. E., Khalaf, R., & Freigeh, G. E. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.08.019 · Cited by 4
Sequence of Immunological Events During IgE ‐Mediated Allergic Reactions to Food
Nagy, N. A., Schnoegl, D., Houghton, V., O’Mahony, L., Santos, A. F., Knol, E. F., Kuehn, A., & Eiwegger, T. (2025) · Allergy · doi:10.1111/all.70194 · Cited by 4
Galeas‐Pena, M., Lyons, J. J., Llivichuzhca-Loja, D., Everman, S., Yaghi, G., White, K., Sutradhar, S., Robinson, T. O., Owings, A. H., Dhaliwal, N. S., et al. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2025.1726096 · Cited by 5
Self-citationUpdate on idiopathic anaphylaxis
Calvani, M. (2022) · Pediatric Allergy and Immunology · doi:10.1111/pai.13629 · Cited by 4
Allergie au venin d’hyménoptère, désordres mastocytaires clonaux et alpha-tryptasémie héréditaire
Chatain, C., & van der Brempt, X. (2021) · Revue française d'allergologie · doi:10.1016/j.reval.2021.10.007 · Cited by 4
Pediatric idiopathic anaphylaxis: practical management from infants to adolescents
Mori, F., Saretta, F., Giovannini, M., Gelsomino, M., Liotti, L., Barni, S., Mastrorilli, C., Pecoraro, L., Castagnoli, R., Arasi, S., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01712-y · Cited by 4
Risk factors in bee and Vespula venom allergy: state of the art
Stoevesandt, J., & Trautmann, A. (2021) · Allergo Journal International · doi:10.1007/s40629-021-00187-1 · Cited by 3
Trends and determinants of epinephrine prescriptions: a proxy of anaphylaxis epidemiology?
Costa, E., Tanno, L. K., Salazzari, D., Tedeschi, F., Andretta, M., & Caminati, M. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000861 · Cited by 3
Systemic diseases affecting the GI tract: A review of clinical and histopathologic manifestations
Pezhouh, M. K., Lam-Himlin, D. M., Zaheer, A., & Voltaggio, L. (2024) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2024.152351 · Cited by 3
Pearls for practice from the 2023 joint task force anaphylaxis practice parameter
Maddukuri, C., Kartha, N., Conway, A. E., & Shaker, M. S. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001397 · Cited by 4
Crupi, F., Caroprese, J., & Mannelli, F. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1592001 · Cited by 2
Therrien, A., Akula, S., Galeas‐Pena, M., Frank, E., Gillette, L., Silvester, J. A., Leffler, D. A., Galvez, J. V., Kelly, C. P., Pozdnyakova, O., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003537 · Cited by 3
Self-citationMohta, A., Narváez-Fernández, E. J., Mir‐Ihara, P., Bartra, J., & Muñoz‐Cano, R. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70194 · Cited by 2
Rijavec, M., Kogovšek, Ž., Inkret, J., Kopač, P., Košnik, M., & Korošec, P. (2026) · Clinical & Experimental Allergy · doi:10.1111/cea.70227 · Cited by 2
Self-citationSexual Dimorphism in Allergic and Mast Cell-Associated Diseases
Kotha, A., Maldonado, T. D., Hamze, H., Hussain, Z. Y., Gobinathan, N., Yao, A. Z., Abudulkadir, M., Ching, J. M., & Ryan, J. J. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09150-w · Cited by 2
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management
Crupi, F., Sordi, B., Vanderwert, F. I., Gesullo, F., Amorosi, A., Mannelli, F., & Santi, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158772 · Cited by 2
Serum tryptase and drug hypersensitivity: why, how and what? A systematic review
Klingebiel, C., Belhocine, W., & Vitte, J. (2023) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000916 · Cited by 2
Mastozytose – eine häufig unerkannte Erkrankung
Muñoz, M., & Siebenhaar, F. (2023) · Die Dermatologie · doi:10.1007/s00105-023-05258-8 · Cited by 2
Hymenoptera anaphylaxis and mast cell activation disorders
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001088 · Cited by 2
Kranyak, A. C., Shuler, M. J., Williams, K. W., & Lee, L. W. (2022) · Pediatric Dermatology · doi:10.1111/pde.15160 · Cited by 2
Blanc, V. L., & Watson, W. T. A. (2024) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-023-00858-4 · Cited by 2
Perioperative anaphylaxis to fibrin sealants in children with Noonan syndrome
Kelly, K. J. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.04.017 · Cited by 2
Shared Transcriptomic Signatures of Inflammaging Among Diverse Strains of Drosophila melanogasterPreprint
Perna, S. I., Tang, W., Blimbaum, S., Li, A., & Zhou, L. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4146509/v1 · Cited by 2
Rydz, A., & Lange, M. (2023) · Forum Dermatologicum · doi:10.5603/fd.96810 · Cited by 2
Točkova, O., Ručigaj, T. P., Ivančan, S., Bidovec‐Stojkovič, U., Rijavec, M., Šelb, J., & Korošec, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136023 · Cited by 1
Self-citationRapid Change in FcεRI Occupancy on Basophils After Venom Immunotherapy Induction
Puxkandl, V., Aigner, S., Burner, T., Lackner, A., Moñino‐Romero, S., Kimeswenger, S., Hoetzenecker, W., & Altrichter, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157511 · Cited by 1
Diagnosis, Prognostication, and Management of Patients With Mastocytosis: Status 2026
Valent, P., & Carter, M. C. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.042 · Cited by 2
Self-citationFainardi, V., Riccò, M., Antignani, R., Bellodi, S., Buono, E. V., Calvani, M., Carbone, R., Cardinale, F., Chiappini, E., Crivellaro, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020678 · Cited by 1
Valent, P., Hartmann, K., Stefanzl, G., Filik, Y., Bauer, K., Degenfeld‐Schonburg, L., Gleixner, K. V., Siebenhaar, F., Niedoszytko, M., Sperr, W. R., et al. (2026) · Current Allergy and Asthma Reports · doi:10.1007/s11882-026-01257-6 · Cited by 1
Weiss, M., Rossignol, J., Campeotto, F., Foy, E., Elbany, C., Jaume, L., Geroux, L., Debeaupuis, O., Neuraz, A., Bekel, L., et al. (2026) · Pediatric Allergy and Immunology · doi:10.1111/pai.70373 · Cited by 1
Immunological and Non-Immunological Risk Factors in Anaphylaxis
Carpio-Escalona, L. V., & González‐de‐Olano, D. (2022) · Current Treatment Options in Allergy · doi:10.1007/s40521-022-00319-0 · Cited by 1
Kepes, J., & Poowuttikul, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-12867-7_25 · Cited by 1
Jiang, M., & Vadas, P. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2203286 · Cited by 1
Dalgıç, C. T. (2023) · Journal of Surgery and Medicine · doi:10.28982/josam.7906 · Cited by 1
Lange, S., Oppel, E. M., Winkler, M., & Ruëff, F. (2024) · Allergologie select · doi:10.5414/alx02524e · Cited by 1
Prevalence of Autoantibodies in Patients with Hereditary Alpha-Tryptasemia
Slapnicar, C. A., Lee, E. Y., & Vadas, P. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000541880 · Cited by 1
Hereditary alpha-tryptasemia and monoclonal mast cell disorders
Chantran, Y., & Arock, M. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1600680 · Cited by 1
Komarow, H. D., Nilsson, G. P., Okayama, Y., Mekori, Y. A., Olivera, A., Valent, P., Hartmann, K., Brockow, K., Cruse, G., Lyons, J. J., et al. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.06.029 · Cited by 1
Self-citationHereditary alpha tryptasemia in identical twins
Bethea, L. H., Tuano, K. S., Seth, N., & Chinen, J. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.06.011 · Cited by 1
How good are mast cell mediators?
Weiler, C. R. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.07.016 · Cited by 1
Mimics of Allergy and Angioedema
Thomas, E. G., & Thomas, D. J. (2021) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2021.09.005 · Cited by 1
La previsión del futuro en la empresa
de Aizpuru, M. A. T. (1987) · Dialnet (Universidad de la Rioja) · Cited by 1
Successful use of a subcutaneous injection port for modified cluster venom immunotherapy
Köksal, Z. G., & Uysal, P. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.10.061
Turner, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00198-5
Risikofaktoren bei Bienen- und Wespengiftallergie: aktuelle Bewertung
Stoevesandt, J., & Trautmann, A. (2022) · Allergo Journal · doi:10.1007/s15007-021-4938-y
Hereditary alpha-tryptasemia: Brief overview of current knowledge and proposal of indications
Chantran, Y., Hirsch, P., Stym‐Popper, G., Barète, S., & Arock, M. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.03.015
Evaluation and diagnosis of mast cell–associated disorders
Park, Y. H., & Lyons, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00020-5
Self-citationGolden, D. B. K., & Carter, M. C. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.05.020
Self-citationApproach to patients with prior near-fatal anaphylaxis
Pouessel, G., Leroy, S., & Deschildre, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96018-2.00111-5
Shared Transcriptomic Signatures of Inflammaging Among Diverse Strains of Drosophila melanogasterPreprint
Perna, S. I., Tang, W., Blimbaum, S., Li, A., & Zhou, L. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576061
Mastozytose – eine häufig unerkannte Erkrankung
Muñoz, M., & Siebenhaar, F. (2024) · best practice onkologie · doi:10.1007/s11654-024-00570-8
Nouveaux critères diagnostiques des mastocytoses : des progrès mais encore des interrogations
Arock, M. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.03.009
Metadata
- Authors
- Lyons, J. J., Chovanec, J., O’Connell, M. P., Liu, Y., Šelb, J., Zanotti, R., Bai, Y., Kim, J., Le, Q. T., DiMaggio, T., Schwartz, L. B., Komarow, H. D., Rijavec, M., Carter, M. C., Milner, J. D., Bonadonna, P., Metcalfe, D. D., & Korošec, P.
- Affiliations
- National Institutes of Health (US)
- University Clinic of Pulmonary and Allergic Diseases Golnik (SI)
- University of Verona (IT)
- Virginia Commonwealth University (US)
- Columbia University (US)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Corresponding author
- Lyons, Jonathan J.
- ORCID
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 147
- Issue
- 2
- Pages
- 622-632
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3044735023
- Cited by
- 230
- References
- 33
- Citations by year
- 2026: 27 · 2025: 31 · 2024: 36 · 2023: 35 · 2022: 43 · 2021: 51
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- hereditary alpha-tryptasemia, TPSAB1, copy number variation, systemic anaphylaxis, idiopathic anaphylaxis, systemic mastocytosis, hymenoptera venom allergy, protease-activated receptor 2, vascular permeability, droplet digital PCR
- MeSH terms
- Adolescent, Adult, Aged, Anaphylaxis, Arthropod Venoms, Child, Female, Genotype, Humans, Male, Middle Aged, Genetic Predisposition to Disease, Mastocytosis, Systemic, Tryptases, Young Adult, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review